Fresenius Medical Care AG & Co. KGaA (FME.DE)
EUR 45.06
(-0.09%)
EUR 45.06
(-0.09%)
| Year | Total Liabilities | Total Liabilities Growth |
|---|---|---|
| 2023 | 19.1 Billion EUR | -5.92% |
| 2022 | 20.3 Billion EUR | -0.41% |
| 2021 | 20.38 Billion EUR | 5.32% |
| 2020 | 19.35 Billion EUR | -1.78% |
| 2019 | 19.7 Billion EUR | 47.74% |
| 2018 | 13.34 Billion EUR | 1.08% |
| 2017 | 13.19 Billion EUR | -10.32% |
| 2016 | 14.71 Billion EUR | 7.0% |
| 2015 | 13.75 Billion EUR | 8.47% |
| 2014 | 12.67 Billion EUR | 28.42% |
| 2013 | 9.87 Billion EUR | -0.46% |
| 2012 | 9.91 Billion EUR | 12.07% |
| 2011 | 8.85 Billion EUR | 23.0% |
| 2010 | 7.19 Billion EUR | 17.28% |
| 2009 | 6.13 Billion EUR | -4.64% |
| 2008 | 6.43 Billion EUR | 10.51% |
| 2007 | 5.82 Billion EUR | -5.12% |
| 2006 | 6.13 Billion EUR | 81.94% |
| 2005 | 3.37 Billion EUR | 6.12% |
| 2004 | 3.17 Billion EUR | -5.71% |
| 2003 | 3.37 Billion EUR | -10.45% |
| 2002 | 3.76 Billion EUR | -13.65% |
| 2001 | 4.35 Billion EUR | 24.88% |
| 2000 | 3.49 Billion EUR | -5.77% |
| 1999 | 3.7 Billion EUR | 31.58% |
| 1998 | 2.81 Billion EUR | 0.0% |
| Year | Total Liabilities | Total Liabilities Growth |
|---|---|---|
| 2024 Q1 | 19.2 Billion EUR | 0.53% |
| 2024 Q3 | 17.72 Billion EUR | -5.29% |
| 2024 Q2 | 18.7 Billion EUR | -2.58% |
| 2023 FY | 19.1 Billion EUR | -5.92% |
| 2023 Q1 | 20.27 Billion EUR | -0.15% |
| 2023 Q2 | 20.02 Billion EUR | -1.2% |
| 2023 Q3 | 20.2 Billion EUR | 0.85% |
| 2023 Q4 | 19.1 Billion EUR | -5.43% |
| 2022 Q4 | 20.3 Billion EUR | -6.3% |
| 2022 FY | 20.3 Billion EUR | -0.41% |
| 2022 Q3 | 21.67 Billion EUR | 5.1% |
| 2022 Q1 | 20.18 Billion EUR | -1.0% |
| 2022 Q2 | 20.61 Billion EUR | 2.15% |
| 2021 Q4 | 20.38 Billion EUR | 0.01% |
| 2021 Q1 | 19.95 Billion EUR | 3.1% |
| 2021 Q2 | 20.17 Billion EUR | 1.08% |
| 2021 Q3 | 20.38 Billion EUR | 1.04% |
| 2021 FY | 20.38 Billion EUR | 5.32% |
| 2020 Q2 | 20.86 Billion EUR | 0.31% |
| 2020 Q4 | 19.35 Billion EUR | -5.08% |
| 2020 Q3 | 20.39 Billion EUR | -2.27% |
| 2020 Q1 | 20.8 Billion EUR | 5.55% |
| 2020 FY | 19.35 Billion EUR | -1.78% |
| 2019 Q3 | 19.62 Billion EUR | 2.46% |
| 2019 Q4 | 19.7 Billion EUR | 0.42% |
| 2019 Q2 | 19.15 Billion EUR | 0.15% |
| 2019 Q1 | 19.12 Billion EUR | 43.38% |
| 2019 FY | 19.7 Billion EUR | 47.74% |
| 2018 Q4 | 13.34 Billion EUR | 0.75% |
| 2018 Q1 | 13.24 Billion EUR | 0.37% |
| 2018 FY | 13.34 Billion EUR | 1.08% |
| 2018 Q2 | 13.06 Billion EUR | -1.35% |
| 2018 Q3 | 13.24 Billion EUR | 1.34% |
| 2017 Q1 | 14.48 Billion EUR | -1.59% |
| 2017 FY | 13.19 Billion EUR | -10.32% |
| 2017 Q4 | 13.19 Billion EUR | -2.8% |
| 2017 Q3 | 13.57 Billion EUR | -3.17% |
| 2017 Q2 | 14.02 Billion EUR | -3.17% |
| 2016 Q4 | 14.71 Billion EUR | 7.06% |
| 2016 Q1 | 13.46 Billion EUR | -2.11% |
| 2016 FY | 14.71 Billion EUR | 7.0% |
| 2016 Q2 | 14.13 Billion EUR | 4.99% |
| 2016 Q3 | 13.74 Billion EUR | -2.76% |
| 2015 Q2 | 13.57 Billion EUR | -1.77% |
| 2015 Q1 | 13.82 Billion EUR | 9.01% |
| 2015 FY | 13.75 Billion EUR | 8.47% |
| 2015 Q4 | 13.75 Billion EUR | 2.0% |
| 2015 Q3 | 13.48 Billion EUR | -0.69% |
| 2014 FY | 12.67 Billion EUR | 28.42% |
| 2014 Q1 | 9.99 Billion EUR | 1.19% |
| 2014 Q2 | 10.62 Billion EUR | 6.33% |
| 2014 Q3 | 11.42 Billion EUR | 7.57% |
| 2014 Q4 | 12.67 Billion EUR | 10.94% |
| 2013 FY | 9.87 Billion EUR | -0.46% |
| 2013 Q4 | 9.87 Billion EUR | -0.84% |
| 2013 Q1 | 9.99 Billion EUR | 0.73% |
| 2013 Q2 | 10.16 Billion EUR | 1.68% |
| 2013 Q3 | 9.95 Billion EUR | -1.99% |
| 2012 Q2 | 10.48 Billion EUR | 8.83% |
| 2012 Q1 | 9.63 Billion EUR | 8.84% |
| 2012 FY | 9.91 Billion EUR | 12.07% |
| 2012 Q4 | 9.91 Billion EUR | -1.77% |
| 2012 Q3 | 10.09 Billion EUR | -3.67% |
| 2011 FY | 8.85 Billion EUR | 23.0% |
| 2011 Q4 | 8.85 Billion EUR | 15.48% |
| 2011 Q3 | 7.66 Billion EUR | -0.32% |
| 2011 Q2 | 7.68 Billion EUR | 13.43% |
| 2011 Q1 | 6.77 Billion EUR | -5.8% |
| 2010 Q4 | 7.19 Billion EUR | 6.29% |
| 2010 Q1 | 6.51 Billion EUR | 6.17% |
| 2010 FY | 7.19 Billion EUR | 17.28% |
| 2010 Q2 | 7.44 Billion EUR | 14.25% |
| 2010 Q3 | 6.77 Billion EUR | -9.04% |
| 2009 Q2 | 6.37 Billion EUR | -1.94% |
| 2009 Q1 | 6.5 Billion EUR | 1.06% |
| 2009 Q4 | 6.13 Billion EUR | 0.0% |
| 2009 FY | 6.13 Billion EUR | -4.64% |
| 2008 Q1 | 5.47 Billion EUR | -5.89% |
| 2008 Q2 | 5.68 Billion EUR | 3.74% |
| 2008 Q3 | 6.19 Billion EUR | 8.96% |
| 2008 Q4 | 6.43 Billion EUR | 3.89% |
| 2008 FY | 6.43 Billion EUR | 10.51% |
| 2007 Q2 | 6.16 Billion EUR | 1.74% |
| 2007 Q1 | 6.06 Billion EUR | -1.19% |
| 2007 FY | 5.82 Billion EUR | -5.12% |
| 2007 Q4 | 5.82 Billion EUR | -0.2% |
| 2007 Q3 | 5.83 Billion EUR | -5.42% |
| 2006 Q3 | 6.27 Billion EUR | -0.88% |
| 2006 Q2 | 6.32 Billion EUR | -11.62% |
| 2006 FY | 6.13 Billion EUR | 81.94% |
| 2006 Q1 | 7.15 Billion EUR | 112.26% |
| 2006 Q4 | 6.13 Billion EUR | -2.15% |
| 2005 FY | 3.37 Billion EUR | 6.12% |
| 2005 Q3 | 3.42 Billion EUR | 0.26% |
| 2005 Q2 | 3.41 Billion EUR | 6.56% |
| 2005 Q1 | 3.2 Billion EUR | 0.97% |
| 2005 Q4 | 3.37 Billion EUR | -1.62% |
| 2004 FY | 3.17 Billion EUR | -5.71% |
| 2004 Q4 | 3.17 Billion EUR | -7.39% |
| 2004 Q3 | 3.43 Billion EUR | -3.73% |
| 2004 Q2 | 3.56 Billion EUR | 0.04% |
| 2004 Q1 | 3.56 Billion EUR | 5.71% |
| 2003 Q4 | 3.37 Billion EUR | -9.75% |
| 2003 FY | 3.37 Billion EUR | -10.45% |
| 2003 Q3 | 3.73 Billion EUR | -0.33% |
| 2003 Q1 | 3.78 Billion EUR | 0.52% |
| 2003 Q2 | 3.74 Billion EUR | -0.97% |
| 2002 Q1 | 4.39 Billion EUR | 0.91% |
| 2002 Q4 | 3.76 Billion EUR | -6.46% |
| 2002 Q2 | 4.03 Billion EUR | -8.36% |
| 2002 Q3 | 4.02 Billion EUR | -0.18% |
| 2002 FY | 3.76 Billion EUR | -13.65% |
| 2001 Q2 | 4.35 Billion EUR | 6.06% |
| 2001 FY | 4.35 Billion EUR | 24.88% |
| 2001 Q4 | 4.35 Billion EUR | 5.71% |
| 2001 Q1 | 4.1 Billion EUR | 17.66% |
| 2001 Q3 | 4.12 Billion EUR | -5.33% |
| 2000 Q2 | 3.76 Billion EUR | 7.7% |
| 2000 Q4 | 3.49 Billion EUR | -7.3% |
| 2000 Q3 | 3.76 Billion EUR | 0.14% |
| 2000 FY | 3.49 Billion EUR | -5.77% |
| 2000 Q1 | 3.49 Billion EUR | -5.75% |
| 1999 FY | 3.7 Billion EUR | 31.58% |
| 1999 Q4 | 3.7 Billion EUR | 0.0% |
| 1998 FY | 2.81 Billion EUR | 0.0% |
| 1998 Q4 | 2.81 Billion EUR | 0.0% |
| Name | Total Liabilities | Total Liabilities Difference |
|---|---|---|
| Fresenius SE & Co. KGaA | 25.63 Billion EUR | 25.474% |
| LIMES Schlosskliniken AG | 16.6 Million EUR | -114941.481% |
| M1 Kliniken AG | 69.72 Million EUR | -27296.286% |
| Maternus-Kliniken Aktiengesellschaft | 206.49 Million EUR | -9151.248% |
| MEDICLIN Aktiengesellschaft | 742.57 Million EUR | -2472.556% |
| RHÖN-KLINIKUM Aktiengesellschaft | 499.09 Million EUR | -3727.56% |
| VITA 34 AG | 135.58 Million EUR | -13989.934% |